The finding that CRP was significantly associated with an increased risk of CVD and decreased the BMI-associated CVD risk substantially, could imply that interleukin-6-related pathways may play a role in mediating overweight- and obesity-related CVD. The gene discussed is CRP; the disease is obesity due to melanocortin 4 receptor deficiency.